Listed

Thermo Fisher Scientific Inc.: Form 10-Q for the period ended Sep 29, 2018

Filed with the SEC on Nov 2, 2018 and accepted by EDGAR at Nov 2, 2018, 11:45 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2018-09-29. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2018-07-01 to 2018-09-29$5.92bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue9 months2018-01-01 to 2018-09-29$17.85bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Research and development3 months2018-07-01 to 2018-09-29$240.0mus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2018-01-01 to 2018-09-29$716.0mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2018-07-01 to 2018-09-29$1.49bnus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2018-01-01 to 2018-09-29$4.55bnus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2018-07-01 to 2018-09-29$912.0mus-gaap:OperatingIncomeLoss
Operating income9 months2018-01-01 to 2018-09-29$2.63bnus-gaap:OperatingIncomeLoss
Interest expense3 months2018-07-01 to 2018-09-29$162.0mus-gaap:InterestExpense
Interest expense9 months2018-01-01 to 2018-09-29$495.0mus-gaap:InterestExpense
Income tax3 months2018-07-01 to 2018-09-29$101.0mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2018-01-01 to 2018-09-29$210.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2018-07-01 to 2018-09-29$709.0mus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Net income9 months2018-01-01 to 2018-09-29$2.04bnus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Diluted EPS3 months2018-07-01 to 2018-09-29$1.75us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2018-01-01 to 2018-09-29$5.03us-gaap:EarningsPerShareDiluted
Basic EPS3 months2018-07-01 to 2018-09-29$1.76us-gaap:EarningsPerShareBasic
Basic EPS9 months2018-01-01 to 2018-09-29$5.07us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2018-07-01 to 2018-09-29406,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2018-01-01 to 2018-09-29406,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2018-01-01 to 2018-09-29$2.74bnus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2018-01-01 to 2018-09-29$474.0mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid9 months2018-01-01 to 2018-09-29$198.0mus-gaap:PaymentsOfDividendsCommonStock
Share repurchases9 months2018-01-01 to 2018-09-29$250.0mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2018-09-29$1.10bnus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2018-09-29$9.57bnus-gaap:AssetsCurrent
Total assetsAt period end2018-09-29$55.08bnus-gaap:Assets
Current liabilitiesAt period end2018-09-29$5.20bnus-gaap:LiabilitiesCurrent
Current portion of debtAt period end2018-09-29$1.01bnus-gaap:DebtCurrent
Shareholders' equityAt period end2018-09-29$26.89bnus-gaap:StockholdersEquity
Shares outstandingAt period end2018-09-29402,576,382 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0000097745-18-000040. Last ingested by Listed: Nov 14, 2026, 12:05 ET. Listed shows no prices and gives no investment advice.